Syros Pharmaceuticals Inc (SYRS)
5.13
-0.08
(-1.54%)
USD |
NASDAQ |
May 03, 16:00
5.13
0.00 (0.00%)
After-Hours: 20:00
Syros Pharmaceuticals Price to Book Value: 8.145 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 02, 2024 | 8.272 |
| May 01, 2024 | 8.637 |
| April 30, 2024 | 8.574 |
| April 29, 2024 | 8.542 |
| April 26, 2024 | 8.002 |
| April 25, 2024 | 8.097 |
| April 24, 2024 | 8.050 |
| April 23, 2024 | 8.161 |
| April 22, 2024 | 7.922 |
| April 19, 2024 | 7.208 |
| April 18, 2024 | 7.494 |
| April 17, 2024 | 8.113 |
| April 16, 2024 | 8.828 |
| April 15, 2024 | 8.494 |
| April 12, 2024 | 8.558 |
| April 11, 2024 | 9.399 |
| April 10, 2024 | 8.780 |
| April 09, 2024 | 8.732 |
| April 08, 2024 | 7.145 |
| April 05, 2024 | 7.414 |
| April 04, 2024 | 7.653 |
| April 03, 2024 | 7.907 |
| April 02, 2024 | 7.359 |
| April 01, 2024 | 8.002 |
| March 28, 2024 | 8.494 |
| Date | Value |
|---|---|
| March 27, 2024 | 9.272 |
| March 26, 2024 | 9.923 |
| March 25, 2024 | 10.16 |
| March 22, 2024 | 9.955 |
| March 21, 2024 | 10.07 |
| March 20, 2024 | 10.05 |
| March 19, 2024 | 9.891 |
| March 18, 2024 | 9.685 |
| March 15, 2024 | 9.542 |
| March 14, 2024 | 9.574 |
| March 13, 2024 | 10.27 |
| March 12, 2024 | 10.26 |
| March 11, 2024 | 10.42 |
| March 08, 2024 | 10.75 |
| March 07, 2024 | 11.00 |
| March 06, 2024 | 11.32 |
| March 05, 2024 | 11.35 |
| March 04, 2024 | 12.06 |
| March 01, 2024 | 12.30 |
| February 29, 2024 | 11.52 |
| February 28, 2024 | 11.41 |
| February 27, 2024 | 11.65 |
| February 26, 2024 | 11.89 |
| February 23, 2024 | 11.52 |
| February 22, 2024 | 11.25 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4291
Minimum
Mar 28 2023
17.91
Maximum
Dec 23 2020
3.685
Average
2.472
Median
Jun 03 2021
Price to Book Value Benchmarks
| PDS Biotechnology Corp | 5.369 |
| PAVmed Inc | -- |
| Moderna Inc | 3.737 |
| Altimmune Inc | 2.670 |
| iBio Inc | 0.7426 |
Price to Book Value Related Metrics
| PS Ratio | 14.63 |
| Price | 5.13 |
| Earnings Yield | -113.1% |
| Market Cap | 135.71M |